The FDA has cleared Senseonics and Ascensia Diabetes Care's Eversense 365 Glucose Monitoring System.

California Gov. Gavin Newsom will soon decide whether to enact new regulations on pharmacy benefit managers in an attempt to address rising prescription drug costs, the Los Angeles Times reported Sept. 16. 

Sanofi received FDA approval for a new manufacturing line to expand production of Beyfortus, a preventive therapy for respiratory syncytial virus in infants. 

The FDA is shutting down a pain management program that has helped supply fentanyl to cancer patients suffering from severe pain, according to a notice from the agency. 

A phase 2 trial of ponsegromab has shown promising results in treating cancer cachexia, a condition that leads to severe weight and muscle loss, according to a study published Sept. 14 in the New England Journal of Medicine. 

A new study found that technology-related errors (TREs) were a significant issue in the computerized physician order entry (CPOE) system of one pediatric hospital, with 1 in 3 prescribing errors being linked to technology.

Walgreens has agreed to pay $106.8 million to resolve allegations of violating the False Claims Act by fraudulently billing government healthcare programs for prescriptions never dispensed, the Department of Justice said in a Sept. 13  news release. 

Sens. Dick Durbin and Mike Braun have introduced legislation to crack down on deceptive online promotions of prescription drugs by telehealth firms and social media influencers. 

University of Illinois Chicago's pharmacy school was gifted a $36 million endowment gift from the estate of late Chicago pharmacy owners Herbert and Carol Retzky, the Chicago Tribune reported Sept. 13. 

Clinical trials for the injectable HIV prevention drug lenacapavir have yielded significant results, with the drug proving 89% more effective than daily oral pre-exposure prophylaxis among gay, bisexual and transgender individuals, NBC News reported Sept. 13.